Publication | Open Access
A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation
22
Citations
38
References
2023
Year
ASO targeting SNORD14E can be an effective treatment for EC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1